Asahi Kasei Medical

Our medical care business contributes to the advancement of medical treatment worldwide via continuous innovation in various fields, including medical device systems that respond to unmet needs (such as chronic and acute renal disease, neurologic diseases and other intractable conditions), filters that improve the quality of blood transfusion products, and products that enable safe and efficient production of biotherapeutics and other medicines at the cutting edge of new drug development.

Trade name Asahi Kasei Medical Co., Ltd.
Main businesses APS™ artificial kidneys, Cellsorba™ leukocytapheresis column, Sepacell™ leukocyte reduction filters, Planova™ virus removal filters
Home office 1-105 Kanda Jinbocho, Chiyoda-ku, Tokyo 101-8101 Japan
President Yutaka Shibata
Paid-in capital ¥3,000 million
Shareholder Asahi Kasei Corp.
Phone +81-(0)3-3296-3750

(as of April 1, 2012)